Streetbeat News

Products Services

YS

YS Biopharma's stock is trading lower following the announcement of interim results from its Phase 3 clinical trial of the PIKA Rabies Vaccine. The news indicates a pivotal moment for the company as it progresses through the clinical trial phase, which is critical for the vaccine's approval and future sales.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:15 pm

NVEI

Nuvei announced that its Singapore entity has been granted a Major Payment Institution License by the Monetary Authority of Singapore, allowing it to offer domestic and cross-border money transfer, along with merchant acquisition services in Singapore.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:11 pm

YS

YS Biopharma announced interim results from a pivotal Phase 3 clinical study of its PIKA Rabies Vaccine, indicating successful meeting of the trial's primary endpoints. This marks a significant milestone in the vaccine's development, potentially impacting its future commercialization and stock value.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:09 pm

COMM

CommScope has introduced a new solution named GigaREACH XL, designed to extend the reach of Category 6 channels, enhancing network infrastructure capabilities.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:07 pm

MYGN

Research conducted by Myriad Genetics has demonstrated that patients with depression experienced a reduction in hospitalizations after undergoing GeneSight testing. This testing helps in tailoring antidepressant treatments based on genetic makeup, potentially leading to more effective management of depression.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:05 pm

AVGO

GOOG

GOOGL

Broadcom announced its decision to migrate its VMWare workloads to Google Cloud, marking a significant partnership between the two tech giants. This move is expected to enhance Broadcom's cloud capabilities and efficiency, while also showcasing Google Cloud's strength in handling large-scale enterprise solutions.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:04 pm

INTC

Deloitte and Intel have expanded their alliance to assist enterprises globally in deploying AI solutions more cost-effectively. This initiative targets the increasing demand for scalable AI implementations that provide tangible benefits across various use cases.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:03 pm

ICAD

iCAD, Inc. has partnered with Densitas to enhance precision in breast health through leading AI solutions. This collaboration aims to leverage the strengths of both companies in artificial intelligence to improve breast cancer detection and patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:01 pm

ALKS

Alkermes shares surged following the announcement of positive topline results from its Phase 1b study of ALKS 2680, aimed at treating Narcolepsy Type 2 and Idiopathic Hypersomnia.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:52 am

SNOA

Sonoma Pharmaceuticals has expanded its Microcyn Negative-pressure Wound Therapy (NPWT) Solution product line in the U.S., introducing sizes of 250mL, 450mL, and 990mL. This advanced wound care solution, which does not promote antibiotic resistance, is designed for effective wound cleaning and irrigation, complementing various negative-pressure therapies and promoting faster healing.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 11:35 am